These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18607151)

  • 41. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
    Srikanth S; Deedwania P
    Curr Hypertens Rep; 2016 Oct; 18(10):76. PubMed ID: 27730495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Water T
    Robinson MD; Mishra I; Deodhar S; Patel V; Gordon KV; Vintimilla R; Brown K; Johnson L; O'Bryant S; Cistola DP
    J Transl Med; 2017 Dec; 15(1):258. PubMed ID: 29258604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.
    Houston MC; Basile J; Bestermann WH; Egan B; Lackland D; Hawkins RG; Moore MA; Reed J; Rogers P; Wise D; Ferrario CM
    Am J Med Sci; 2005 Jun; 329(6):276-91. PubMed ID: 15958870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A constellation of complications: the metabolic syndrome.
    Grundy SM
    Clin Cornerstone; 2005; 7(2-3):36-45. PubMed ID: 16473259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus.
    Barchetta I; Ceccarelli V; Cimini FA; Bertoccini L; Fraioli A; Alessandri C; Lenzi A; Baroni MG; Cavallo MG
    J Endocrinol Invest; 2019 May; 42(5):513-520. PubMed ID: 30132286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice.
    Bellan M; Menegatti M; Ferrari C; Carnevale Schianca GP; Pirisi M
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):610-617. PubMed ID: 29656956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance.
    Grundy SM
    Clin Cornerstone; 2006; 8 Suppl 1():S21-7. PubMed ID: 16903166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
    Deedwania PC; Maki KC; Dicklin MR; Stone NJ; Ballantyne CM; Davidson MH
    J Cardiometab Syndr; 2006; 1(5):295-300. PubMed ID: 17679790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The metabolic syndrome and inflammation: association or causation?
    Esposito K; Giugliano D
    Nutr Metab Cardiovasc Dis; 2004 Oct; 14(5):228-32. PubMed ID: 15673055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epidemiological data and screening criteria of the metabolic syndrome].
    Boulogne A; Vantyghem MC
    Presse Med; 2004 Jun; 33(10):662-5, 681. PubMed ID: 15257240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity.
    Robinson LE; Graham TE
    Can J Appl Physiol; 2004 Dec; 29(6):808-29. PubMed ID: 15630152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Relation between sexual dysfunction and metabolic syndrome].
    Zsoldos M; Pajor A; Pusztafalvi H
    Orv Hetil; 2019 Jan; 160(3):98-103. PubMed ID: 30640528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children.
    Kelly AS; Steinberger J; Kaiser DR; Olson TP; Bank AJ; Dengel DR
    J Cardiometab Syndr; 2006; 1(4):248-52. PubMed ID: 17679810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors.
    Silveira Rossi JL; Barbalho SM; Reverete de Araujo R; Bechara MD; Sloan KP; Sloan LA
    Diabetes Metab Res Rev; 2022 Mar; 38(3):e3502. PubMed ID: 34614543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thyroid Hormones, Metabolic Syndrome and Its Components.
    Delitala AP; Fanciulli G; Pes GM; Maioli M; Delitala G
    Endocr Metab Immune Disord Drug Targets; 2017; 17(1):56-62. PubMed ID: 28322173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C-reactive protein, metabolic syndrome, and insulin resistance in individuals with spinal cord injury.
    Lee MY; Myers J; Hayes A; Madan S; Froelicher VF; Perkash I; Kiratli BJ
    J Spinal Cord Med; 2005; 28(1):20-5. PubMed ID: 15832900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of age and sex with cardiovascular risk factors and insulin sensitivity in overweight children and adolescents.
    Koenigsberg J; Boyd GS; Gidding SS; Hassink SG; Falkner B
    J Cardiometab Syndr; 2006; 1(4):253-8. PubMed ID: 17679813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Association of physical inactivity with obesity, diabetes, hypertension and metabolic syndrome in the chilean population].
    Díaz-Martínez X; Petermann F; Leiva AM; Garrido-Méndez A; Salas-Bravo C; Martínez MA; Labraña AM; Duran E; Valdivia-Moral P; Zagalaz ML; Poblete-Valderrama F; Alvarez C; Celis-Morales C
    Rev Med Chil; 2018 May; 146(5):585-595. PubMed ID: 30148922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome.
    Venkatapuram S; Shannon RP
    Am J Ther; 2006; 13(1):64-71. PubMed ID: 16428924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.